Matar H - Search Results

1

Development of a cumulative irritation model for incontinence-associated dermatitis.

Larner J, Matar H, Goldman VS, Chilcott RP. Larner J, et al. Among authors: matar h. Arch Dermatol Res. 2015 Jan;307(1):39-48. doi: 10.1007/s00403-014-1526-y. Epub 2014 Nov 22. Arch Dermatol Res. 2015. PMID: 25416151

2

Evaluation of a new topical skin protectant (RD1433) for the prevention and treatment of incontinence-associated dermatitis.

Matar H, Larner J, Viegas V, Kansagra S, Atkinson KL, Shetage S, Skamarauskas JT, Theivendran B, Goldman VS, Chilcott RP. Matar H, et al. Cutan Ocul Toxicol. 2017 Sep;36(3):211-219. doi: 10.1080/15569527.2016.1257637. Epub 2016 Nov 23. Cutan Ocul Toxicol. 2017. PMID: 27817210 Clinical Trial.

3

Optimisation of a dosing regime for a topical skin protectant (barrier cream).

Chilcott RP, Larner J, Matar H, Kansagra S, Theivendran B, Viegas VA, Goldman VS. Chilcott RP, et al. Among authors: matar h. Cutan Ocul Toxicol. 2015;34(4):327-34. doi: 10.3109/15569527.2014.994124. Epub 2015 Jan 19. Cutan Ocul Toxicol. 2015. PMID: 25597377 Clinical Trial.

4

Hybrid in vitro diffusion cell for simultaneous evaluation of hair and skin decontamination: temporal distribution of chemical contaminants.

Matar H, Amer N, Kansagra S, Pinhal A, Thomas E, Townend S, Larner J, Chilcott RP. Matar H, et al. Sci Rep. 2018 Nov 15;8(1):16906. doi: 10.1038/s41598-018-35105-z. Sci Rep. 2018. PMID: 30443008 Free PMC article.

5

Design and characterisation of a novel in vitro skin diffusion cell system for assessing mass casualty decontamination systems.

Matar H, Larner J, Kansagra S, Atkinson KL, Skamarauskas JT, Amlot R, Chilcott RP. Matar H, et al. Toxicol In Vitro. 2014 Jun;28(4):492-501. doi: 10.1016/j.tiv.2014.01.001. Epub 2014 Jan 8. Toxicol In Vitro. 2014. PMID: 24412538

6

[No title available]

[No authors listed] [No authors listed] PMID: 26271021

7

Efficacy of Different Hair and Skin Decontamination Strategies with Identification of Associated Hazards to First Responders.

Larner J, Durrant A, Hughes P, Mahalingam D, Rivers S, Matar H, Thomas E, Barrett M, Pinhal A, Amer N, Hall C, Jackson T, Catalani V, Chilcott RP. Larner J, et al. Among authors: matar h. Prehosp Emerg Care. 2020 May-Jun;24(3):355-368. doi: 10.1080/10903127.2019.1636912. Epub 2019 Jul 19. Prehosp Emerg Care. 2020. PMID: 31251095

8

The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.

Lydon H, Hall C, Matar H, Dalton C, Chipman JK, Graham JS, Chilcott RP. Lydon H, et al. Among authors: matar h. J Appl Toxicol. 2018 Mar;38(3):318-328. doi: 10.1002/jat.3542. Epub 2017 Oct 10. J Appl Toxicol. 2018. PMID: 29023806

9

Mass Casualty Decontamination in the United States: An Online Survey of Current Practice.

Power S, Symons C, Carter H, Jones E, Amlôt R, Larner J, Matar H, Chilcott RP. Power S, et al. Among authors: matar h. Health Secur. 2016 Jul-Aug;14(4):226-36. doi: 10.1089/hs.2016.0047. Epub 2016 Jul 21. Health Secur. 2016. PMID: 27442794 Free PMC article.

10

Further studies of the efficacy of military, commercial and novel skin decontaminants against the chemical warfare agents sulphur Mustard, Soman and VX.

Matar H, Price SC, Chilcott RP. Matar H, et al. Toxicol In Vitro. 2019 Feb;54:263-268. doi: 10.1016/j.tiv.2018.10.008. Epub 2018 Oct 19. Toxicol In Vitro. 2019. PMID: 30347232

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results